Cargando…

Determinants of exercise intolerance in breast cancer patients prior to anthracycline chemotherapy

Women with early‐stage breast cancer have reduced peak exercise oxygen uptake (peak VO(2)). The purpose of this study was to evaluate peak VO(2) and right (RV) and left (LV) ventricular function prior to adjuvant chemotherapy. Twenty‐nine early‐stage breast cancer patients (mean age: 48 years) and 1...

Descripción completa

Detalles Bibliográficos
Autores principales:	Beaudry, Rhys I., Howden, Erin J., Foulkes, Steve, Bigaran, Ashley, Claus, Piet, Haykowsky, Mark J., Gerche, Andre La
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2019
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6328913/ https://www.ncbi.nlm.nih.gov/pubmed/30632311 http://dx.doi.org/10.14814/phy2.13971

Ejemplares similares

Exercise Attenuates Cardiotoxicity of Anthracycline Chemotherapy Measured by Global Longitudinal Strain
por: Costello, Benedict T., et al.
Publicado: (2019)

Exercise as a diagnostic and therapeutic tool for preventing cardiovascular morbidity in breast cancer patients– the BReast cancer EXercise InTervention (BREXIT) trial protocol
por: Foulkes, Stephen J., et al.
Publicado: (2020)

Cardiac and skeletal muscle predictors of impaired cardiorespiratory fitness post-anthracycline chemotherapy for breast cancer
por: Kirkham, Amy A., et al.
Publicado: (2021)

Exercise cardiovascular magnetic resonance reveals reduced cardiac reserve in pediatric cancer survivors with impaired cardiopulmonary fitness
por: Foulkes, Stephen, et al.
Publicado: (2020)

Cardiac mechanisms for low aerobic power in anthracycline treated, older, long-term breast cancer survivors
por: Beaudry, Rhys I., et al.
Publicado: (2022)

The Utility of Cardiac Reserve for the Early Detection of Cancer Treatment-Related Cardiac Dysfunction: A Comprehensive Overview
por: Foulkes, Stephen, et al.
Publicado: (2020)

Improvements in exercise capacity following cardiac transplantation in a patient born with double inlet left ventricle
por: Selig, Steve, et al.
Publicado: (2018)

Cellular Mechanisms Mediating Exercise-Induced Protection against Cardiotoxic Anthracycline Cancer Therapy
por: Dozic, Sanela, et al.
Publicado: (2023)

Exercise intolerance in heart failure with preserved ejection fraction: more than a heart problem
por: Upadhya, Bharathi, et al.
Publicado: (2015)

Degree of diffuse fibrosis measured by MRI correlates with LV remodelling in childhood cancer survivors after anthracycline chemotherapy
por: Tham, Edythe B, et al.
Publicado: (2011)

Case of Anthracycline-induced Cardiogenic Shock: A Call to Optimize Modifiable Cardiac Risk Factors Prior to Chemotherapy
por: Gabriel, Andre, et al.
Publicado: (2019)

Anthracycline Chemotherapy and Cardiotoxicity
por: McGowan, John V, et al.
Publicado: (2017)

Atrial volume and function during exercise in health and disease
por: Schnell, Frédéric, et al.
Publicado: (2017)

Role of baseline echocardiography prior to initiation of anthracycline-based chemotherapy in breast cancer patients
por: Mina, Alain, et al.
Publicado: (2015)

Meta-analysis of Exercise Training on Vascular Endothelial Function in Cancer Survivors
por: Beaudry, Rhys I., et al.
Publicado: (2018)

Advances in anthracycline chemotherapy : epirubicin /
Publicado: (1984)

Aerosol Generation During High Intensity Exercise—Implications for COVID-19 Transmission
por: Cowie, Brian, et al.
Publicado: (2023)

Diffuse myocardial fibrosis by T(1)-mapping in children with subclinical anthracycline cardiotoxicity: relationship to exercise capacity, cumulative dose and remodeling
por: Tham, Edythe B, et al.
Publicado: (2013)

Rapid cardiovascular aging following allogeneic hematopoietic cell transplantation for hematological malignancy
por: Dillon, Hayley T., et al.
Publicado: (2022)

Reduced cardiovascular reserve capacity in long-term allogeneic stem cell transplant survivors
por: Dillon, Hayley T., et al.
Publicado: (2023)

Dynamic aspects of ventricular interaction during exercise in HFpEF and in pre‐capillary pulmonary hypertension
por: Claeys, Mathias, et al.
Publicado: (2022)

A novel scoring system to estimate chemotherapy-induced myocardial toxicity: Risk assessment prior to non-anthracycline chemotherapy regimens
por: Öztürk, Can, et al.
Publicado: (2021)

Evaluation of biomarkers for cardiotoxicity of anthracyclin-based chemotherapy
por: Broeyer, F. J. F., et al.
Publicado: (2008)

What Limits Cardiac Performance during Exercise in Normal Subjects and in Healthy Fontan Patients?
por: La Gerche, André, et al.
Publicado: (2010)

RBL2 Regulates Cardiac Sensitivity to Anthracycline Chemotherapy
por: Xia, Peng, et al.
Publicado: (2023)

Pulmonary Vascular and Right Ventricular Reserve in Patients With Normalized Resting Hemodynamics After Pulmonary Endarterectomy
por: Claessen, Guido, et al.
Publicado: (2015)

Cardiotoxicity of Non-Anthracycline Cancer Chemotherapy Agents
por: Briasoulis, Alexandros, et al.
Publicado: (2022)

Preventing the adverse cardiovascular consequences of allogeneic stem cell transplantation with a multi-faceted exercise intervention: the ALLO-Active trial protocol
por: Dillon, Hayley T., et al.
Publicado: (2022)

Left Ventricle Size Correlates with Peak Exercise Capacity in Pediatric Cancer Survivors Exposed to Anthracycline Chemotherapy
por: Masood, Imran Ross, et al.
Publicado: (2023)

Systemic autophagy in the therapeutic response to anthracycline-based chemotherapy
por: Castoldi, Francesca, et al.
Publicado: (2018)

Exercise Intolerance in Pulmonary Arterial Hypertension
por: Fowler, Robin M., et al.
Publicado: (2012)

Burden of chronic diseases among sarcoma survivors treated with anthracycline chemotherapy: results from an observational study
por: Baker, Laurence H., et al.
Publicado: (2020)

Risk Factors for Exercise-Associated Sudden Cardiac Death in Thoroughbred Racehorses
por: Nath, Laura, et al.
Publicado: (2022)

Identification and Validation of an Anthracycline/Cyclophosphamide–Based Chemotherapy Response Assay in Breast Cancer
por: Mulligan, Jude M., et al.
Publicado: (2014)

Effect of respiration on cardiac filling at rest and during exercise in Fontan patients: A clinical and computational modeling study
por: Van De Bruaene, Alexander, et al.
Publicado: (2015)

Cardiotoxicity by Anthracycline Regimen Chemotherapy Prolonged T Peak to T End Interval
por: Iqbal, Mohammad, et al.
Publicado: (2020)

Exercise to Reduce Anthracycline-Mediated Cardiovascular Complications in Breast Cancer Survivors
por: Varghese, Sonu S., et al.
Publicado: (2021)

The comparison of anthracycline-based and non-anthracycline-based regimens in adjuvant chemotherapy of HER2-positive non-metastatic breast cancers
por: Najafi, Safa, et al.
Publicado: (2018)

Additional effect of anthracycline in preoperative chemotherapy with a sequential anthracycline‑containing regimen preceded by pertuzumab, trastuzumab and docetaxel combination therapy
por: Shima, Hiroaki, et al.
Publicado: (2022)

The role of front-line anthracycline-containing chemotherapy regimens in peripheral T-cell lymphomas
por: Briski, R, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_85eqi8arhos539omtvrsue9ji9